Companies: 10,795·Total market cap: $144.5T
Milestone Scientific Inc.

Milestone Scientific Inc.

MLSSAMEXHealthcare● Active
$0.38
$-0.00(-0.55%)
Market Cap$33715187
P/E Ratio
52W High$0.92
52W Low$0.22
Overview

Milestone Scientific Inc. (MLSS) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

mlss · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Milestone Scientific Inc. (MLSS) measures how much investors pay for each dollar of the company's trailing earnings. MLSS's current PE ratio of N/A is calculated by dividing its stock price of $0.38 by its TTM earnings per share of -$0.06.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2026 est. EPS $-0.04
Based on 2 analysts
EPS (TTM)
-$0.06
TTM · diluted EPS
PEG Ratio
4.58
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Milestone Scientific Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2006 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 19.9x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Instruments & Supplies · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Milestone Scientific Inc.
Milestone Scientific Inc.You
MLSS
$34MN/A-$0.06
Apimeds Pharmaceuticals US, Inc
Apimeds Pharmaceuticals US, Inc
APUS
$1MN/A-$0.55
Harvard Bioscience, Inc.
Harvard Bioscience, Inc.
HBIO
$26MN/A-$12.77
IGC Pharma, Inc.
IGC Pharma, Inc.
IGC
$29MN/A-$0.07
MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc.
MIRA
$42MN/A-$0.44
Myomo, Inc.
Myomo, Inc.
MYO
$54MN/A-$0.37
Nutriband Inc.
Nutriband Inc.
NTRB
$42MN/A-$0.71

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.07
2024-12-31
FY2024
$-0.06
2023-12-31
FY2023
$-0.10
2022-12-31
FY2022
$-0.12
2021-12-31
FY2021
$-0.10
2020-12-31
FY2020
$-0.12
2019-12-31
FY2019
$-0.16
2018-12-31
FY2018
$-0.21
2017-12-31
FY2017
$-0.16
2016-12-31
FY2016
$-0.22

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Milestone Scientific Inc. (MLSS) measures how much investors pay for each dollar of the company's trailing earnings. MLSS's current PE ratio of N/A is calculated by dividing its stock price of $0.38 by its TTM earnings per share of -$0.06.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.38 ÷ -$0.06 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

MLSS pe ratio · 6 questions

MLSS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.38 and TTM EPS of -$0.06. Data sourced from Financial Modeling Prep via MLSS's SEC 10-K and 10-Q filings.

MLSS PE ratioWhat is MLSS PE ratioCurrent PE ratio of MLSSMLSS PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Milestone Scientific Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09